Deerfield Management Company, L.P. (Series C) Adverum Biotechnologies, Inc. Transaction History

Deerfield Management Company, L.P. (Series C)

$5.38 Billion
Q3 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$2.08 - $3.6 $5.88 Million - $10.2 Million	-2,827,000 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$3.36 - $10.56 $1.42 Million - $4.46 Million	422,561 Added 17.57%	2,827,000 $9.9 Million
Q3 2020 Nov 16, 2020	BUY	$10.3 - $21.64 $16.2 Million - $34 Million	1,570,544 Added 188.34%	2,404,439 $24.8 Million
Q2 2020 Aug 14, 2020	SELL	$8.53 - $25.64 $10.6 Million - $31.8 Million	-1,241,105 Reduced 59.81%	833,895 $17.4 Million
Q1 2020 May 15, 2020	BUY	$7.98 - $16.32 $14.9 Million - $30.4 Million	1,863,657 Added 881.82%	2,075,000 $20.3 Million
Q4 2019 Feb 14, 2020	BUY	$5.12 - $12.22 $1.08 Million - $2.58 Million	211,343 New	211,343 $2.44 Million
Q2 2018 Aug 14, 2018	SELL	$5.3 - $6.9 $2.24 Million - $2.91 Million	-422,000 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$3.65 - $7.95 $1.54 Million - $3.35 Million	422,000 New	422,000 $2.45 Million

Others Institutions Holding ADVM

# of Institutions

Shares Held

524K

Call Options Held

Put Options Held

Versant Venture Management, LLC San Francisco, CA

507K
Shares

$2.16 Million
9.32% of portfolio
Pinz Capital Management, LP New York, NY

15.7K
Shares

$67,039
0.03% of portfolio
American Portfolios Advisors Holbrook, NY

1.15K
Shares

$4,910
0.0% of portfolio

View Full List

About Adverum Biotechnologies, Inc.

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $424M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

More about ADVM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.

Account